Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Benefits of the Measureof Epicardial Adipose Tissue During Coronary Calcium Assessment of the Refine Cardiovascular Risk Assessment at Reunion Island.

NCT07090629 is registered in ClinicalTrials.gov with Centre Hospitalier Universitaire de la Réunion as lead sponsor.

NCT NCT07090629
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07090629 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Benefits of the Measureof Epicardial Adipose Tissue During Coronary Calcium Assessment of the Refine Cardiovascular Risk Assessment at Reunion Island.
Lead sponsor
Centre Hospitalier Universitaire de la Réunion
Phase
Observational
Overall status
Completed
Start date
May 6, 2024
Completion date
March 21, 2025
Enrollment
126 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes, high cholesterol, lipodystrophy, familial partial